• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因莫氏显微外科手术而转诊时发生同步和异时性第二原发性非黑色素瘤皮肤癌的风险。

Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.

作者信息

Schinstine M, Goldman G D

机构信息

University of Vermont College of Medicine and Fletcher Allen Health Care Center, UHC Campus, Burlington, Vermont 05401, USA.

出版信息

J Am Acad Dermatol. 2001 Mar;44(3):497-9. doi: 10.1067/mjd.2001.110646.

DOI:10.1067/mjd.2001.110646
PMID:11209121
Abstract

BACKGROUND

Patients with basal cell carcinoma and cutaneous squamous cell carcinoma are at substantial risk for the onset of a second nonmelanoma skin cancer (NMSC).

OBJECTIVE

Our purpose was to determine the incidence of multiple (synchronous) NMSC at presentation to an academic Mohs micrographic surgery referral center and to note the incidence of second lesions occurring in a metachronous fashion.

METHODS

A retrospective study was conducted of 456 consecutive patients who presented for Mohs surgery over a 2-year period. Patients were assessed at initial visits for the presence of multiple NMSCs and were subsequently examined over 2 years for the onset of new NMSCs.

RESULTS

More than 39% of patients initially referred for Mohs surgery with a basal cell or squamous cell carcinoma either presented with multiple primary lesions or experienced a subsequent NMSC within 2 years. These tumors were divided almost equally between multiple primary NMSC at presentation and subsequent (metachronous) tumors.

CONCLUSION

Patients referred for Mohs surgery in an academic setting are a select group at extremely high risk of additional NMSCs at or shortly after presentation for the index lesion.

摘要

背景

基底细胞癌和皮肤鳞状细胞癌患者发生第二种非黑色素瘤皮肤癌(NMSC)的风险很大。

目的

我们的目的是确定在一家学术性莫氏显微外科转诊中心就诊时多发(同步)NMSC的发生率,并记录异时发生的第二种病变的发生率。

方法

对在两年期间连续接受莫氏手术的456例患者进行了一项回顾性研究。在初次就诊时评估患者是否存在多发NMSC,随后在两年内对患者进行检查,以观察新的NMSC的发生情况。

结果

最初因基底细胞癌或鳞状细胞癌而转诊接受莫氏手术的患者中,超过39%的患者要么初诊时就有多个原发性病变,要么在两年内出现了后续的NMSC。这些肿瘤在初诊时的多发原发性NMSC和后续(异时性)肿瘤之间几乎平均分布。

结论

在学术环境中被转诊接受莫氏手术的患者是一个特定的群体,在因索引病变就诊时或就诊后不久发生额外NMSC的风险极高。

相似文献

1
Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.因莫氏显微外科手术而转诊时发生同步和异时性第二原发性非黑色素瘤皮肤癌的风险。
J Am Acad Dermatol. 2001 Mar;44(3):497-9. doi: 10.1067/mjd.2001.110646.
2
Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.耳部非黑色素瘤皮肤癌:亚解剖位置与莫氏显微外科手术后缺损大小之间的相关性
Dermatol Surg. 2009 Jan;35(1):30-3. doi: 10.1111/j.1524-4725.2008.34379.x. Epub 2008 Nov 19.
3
Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.莫氏显微外科手术与传统手术切除:成本比较分析
Arch Dermatol. 2004 Jun;140(6):736-42. doi: 10.1001/archderm.140.6.736.
4
Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.非黑色素瘤皮肤癌治疗中的手术切缘与莫氏显微外科手术
Curr Surg. 2005 Sep-Oct;62(5):518-26. doi: 10.1016/j.cursur.2005.01.003.
5
Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.术前活检后残留皮肤癌:通过莫氏显微外科手术进行评估。
Int J Dermatol. 2004 Jun;43(6):456-8. doi: 10.1111/j.1365-4632.2004.02129.x.
6
Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.在莫氏显微外科手术中对非黑色素瘤皮肤癌进行创新的19分钟快速细胞角蛋白免疫染色。
Dermatol Surg. 2009 Jul;35(7):1050-6. doi: 10.1111/j.1524-4725.2009.01182.x. Epub 2009 May 15.
7
Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.基于Mohs 显微外科的皮肤恶性病变建议切除边界。
JAMA Facial Plast Surg. 2013 Sep-Oct;15(5):337-43. doi: 10.1001/jamafacial.2013.1011.
8
Mohs' micrographic surgery for nonmelanoma skin cancers.用于非黑色素瘤皮肤癌的莫氏显微外科手术。
Clin Plast Surg. 1997 Oct;24(4):705-18.
9
Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.非黑色素瘤皮肤癌诊断后的第二原发性癌症风险及死亡风险
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2584-90. doi: 10.1158/1055-9965.EPI-05-0379.
10
Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.莫氏手术合理使用标准:在单一学术中心对非黑色素瘤皮肤癌进行回顾性应用。
Dermatol Surg. 2015 Aug;41(8):889-95. doi: 10.1097/DSS.0000000000000412.

引用本文的文献

1
The incidence and clinical analysis of non-melanoma skin cancer.非黑色素瘤皮肤癌的发病情况与临床分析。
Sci Rep. 2021 Feb 22;11(1):4337. doi: 10.1038/s41598-021-83502-8.
2
Squamous Cell Carcinoma in-situ and Basal Cell Carcinoma Arising From Seborrheic Keratosis in the Same Patient.同一患者脂溢性角化病并发原位鳞状细胞癌和基底细胞癌
Indian J Dermatol. 2016 Jan-Feb;61(1):126. doi: 10.4103/0019-5154.174178.
3
Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.基底细胞癌:发病机制、流行病学、临床特征、诊断、组织病理学及治疗
Yale J Biol Med. 2015 Jun 1;88(2):167-79. eCollection 2015 Jun.
4
Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.核形态计量学可识别出皮肤鳞状细胞癌中具有独特侵袭性的细胞表型。
Cancer Prev Res (Phila). 2011 Nov;4(11):1770-7. doi: 10.1158/1940-6207.CAPR-10-0404. Epub 2011 Jun 2.
5
Nonmelanoma skin cancer in India: current scenario.印度的非黑色素瘤皮肤癌:现状
Indian J Dermatol. 2010 Oct;55(4):373-8. doi: 10.4103/0019-5154.74551.